Scientific and therapeutic advances in antiplatelet therapy.

作者： Deepak L. Bhatt , Eric J. Topol

DOI: 10.1038/NRD985

关键词: Pharmacology 、 Mediator 、 Bioinformatics 、 Randomized controlled trial 、 Revascularization 、 Thrombosis 、 Platelet 、 Medicine

摘要: … In their well-known meta-analysis, the Antiplatelet Trialists' … low-molecular-weight heparin enoxaparin for acute myocardial … to lower CD40L expression in patients undergoing PCI. Thus …

nih.gov 本地加速

nature.com 本地加速

nature.com 本地加速

nature.com LINK 下载加速

nature.com PDF 下载加速

sci-hub.se PDF 下载加速

academia.edu PDF 下载加速

参考文章(174)

C. Napoli, G. Cirino, P. Del Soldato, R. Sorrentino, V. Sica, M. Condorelli, A. Pinto, L. J. Ignarro, Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 98, pp. 2860- 2864 ,(2001) , 10.1073/PNAS.041602898

Uwe Schönbeck, François Mach, Galina K. Sukhova, Michael Herman, Pierre Graber, Marilyn R. Kehry, Peter Libby, CD40 ligation induces tissue factor expression in human vascular smooth muscle cells. American Journal of Pathology. ,vol. 156, pp. 7- 14 ,(2000) , 10.1016/S0002-9440(10)64699-8

David J Schneider, Douglas J Taatjes, Burton E Sobel, Paradoxical inhibition of fibrinogen binding and potentiation of α-granule release by specific types of inhibitors of glycoprotein IIb–IIIa Cardiovascular Research. ,vol. 45, pp. 437- 446 ,(2000) , 10.1016/S0008-6363(99)00253-9

U Klinkhardt, Clopidogrel, but not abciximab, reduces platelet leukocyte conjugates and P‐selectin expression in a human ex vivo in vitro model Clinical Pharmacology & Therapeutics. ,vol. 71, pp. 176- 185 ,(2002) , 10.1067/MCP.2002.122018

Pål Aukrust, Fredrik Müller, Thor Ueland, Trude Berget, Elinor Aaser, Anne Brunsvig, Nils Olav Solum, Kolbjørn Forfang, Stig S. Frøland, Lars Gullestad, Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina Possible Reflection of T Lymphocyte and Platelet Involvement in the Pathogenesis of Acute Coronary Syndromes Circulation. ,vol. 100, pp. 614- 620 ,(1999) , 10.1161/01.CIR.100.6.614

Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. The Lancet. ,vol. 357, pp. 1905- 1914 ,(2001) , 10.1016/S0140-6736(00)05059-5

Andreas Schober, David Manka, Philipp von Hundelshausen, Yuqing Huo, Peter Hanrath, Ian J. Sarembock, Klaus Ley, Christian Weber, Deposition of Platelet RANTES Triggering Monocyte Recruitment Requires P-Selectin and Is Involved in Neointima Formation After Arterial Injury Circulation. ,vol. 106, pp. 1523- 1529 ,(2002) , 10.1161/01.CIR.0000028590.02477.6F

J. E. Sadler, A new name in thrombosis, ADAMTS13 Proceedings of the National Academy of Sciences of the United States of America. ,vol. 99, pp. 11552- 11554 ,(2002) , 10.1073/PNAS.192448999

Paul M Ridker, Charles H Hennekens, Christian Schmitz, Meir J Stampfer, Klaus Lindpaintner, None, PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis The Lancet. ,vol. 349, pp. 385- 388 ,(1997) , 10.1016/S0140-6736(97)80010-4

L. Kristin Newby, E. Magnus Ohman, Robert H. Christenson, David J. Moliterno, Robert A. Harrington, Harvey D. White, Paul W. Armstrong, Frans Van de Werf, Matthias Pfisterer, Vic Hasselblad, Robert M. Califf, Eric J. Topol, Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy. Circulation. ,vol. 103, pp. 2891- 2896 ,(2001) , 10.1161/01.CIR.103.24.2891